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SUCCESSFUL LIVER TRANSPLANTATION FOR ISONIAZID-INDUCED HEPATIC FAILURE-A CASE REPORT1 
A 6-12-month course of isoniazid (INH)* has been recom-
mended as prophylaxis against tuberculosis for individuals 
having an asymptomatic positive tuberculin skin test ( 1. 21. 
Isoniazid is known to cause an elevation of liver enzymes 
(3-5). which usually improves after INH is discontinued. 
However. INH mav sometimes cause fatal hepatic necrosis 
((>-9 ). 
Liver transplantation has been reported to be effective for 
drug-Induced hepatic failure of multiple etiologies (10-13), 
However. there have been no reports of liver transplantation 
for lNH-induced hepatic failure. We describe here the case of 
~ 1 This work was supported in part by rt'senrch grants from the 
, Veterans Admlnlstratlon and Project Grant DK·29961 from the Na· t tlOnal institutes ot Health. Bethesda. MD. 
• • Abb~~"I""D INH. '''m""d. 
a I6-year-old girl who developed hepatic failure following a 
:3-month course of INH use and was successfully treated with 
liver transplantation. 
In September 1992, an otherwise healthy 16-year-old girl 
displayed a positive PPD skin test by routine examination. 
with a normal chest roentgenogram. She was placed on pro-
phylactic doses of INH and pyridoxine. The lNH was dis-
continued in late December, after she developed lethan..'Y. 
weakness, and loss of appetite. In early January 1993. she 
was found to have scleral icterus. abnormal liver function 
tests, and coagulopathy (serum glutam1c oxaloacetlc 
transaminase 328 lUlL, glutamic pyruvic transaminase 313 
lUlL. alkaline phosphatase 350 lUlL, total bilirubin 104 
mg/dl. prothrombin time 20 sec, partial thromboplastin time 
122 sec. ammoma 86 llmol/Ll. She was hospItalized and was 
,;tarted on lactulose. neomycin. cimetldine and vitamin K. 
After 2 weeks. her total bilirubin decreased to 8.4 mg/dl. 
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FIGURE 1. Computenzed tomography scan of the abdomen showing a diminished Size heterogenous liver with calcified nodules. 
~serum glutamic oxaloacetic transaminase decrea. sed to 203 lUlL. and ammonia decreased to 60 pmoUdl: however. her 
prothrombin time and partial thromboplastin time did not 
, improve despite administration of fresh frozen plasma sev-
eral times. She had not experienced episodes of bleeding or 
encephalopathy. She was transferred to our Institution for 
possible liver transplantation. She had a firm liver without 
signs of portal hypertensIOn. Computerized tomography 
scanmng showed a diminIshed-size heterogeneous liver with 
calcified nodules (Fig. ll. There was no ascites or spleno-
megaly. Hepatitis A. B. C screens were negative. Serum 
alpha-I-antitrypsin. alpha-fetoproteln. copper. and cerulo-
plasmin levels were within normal ranges. Anti-smooth 
muscle. anti-DNA. anti-RNA. and antimicrosomal antibod-
ies were negative. Cytomegalovirus and Epstein-Barr virus 
titers were negative. A chest roentgenogram was normal. 
Cultures from the sputa were negative. 
In early February. she underwent orthotopIc liver trans-
plantatIOn. Using the liver from a 10-year-old donor. the 
transplant was done with a transient portocaval shunt bv the 
piggy-back method (141. An artenal graft was Interposed 
between the Infrarenal aorta and a small hepatic artery. The 
postoperative course was uneventful except for transient 
bleedmg from a Roux-en-Y loop. which was treated with 
blood transfusion. Immunosuppression was with FK506 and 
steroids. Since her transplant. she has been on ethambutol 
and pyrazinamide contlnuouslv as antituberculosIs prophy-
.laxis.She had no epl,sodes of rejectIOn or tnl:ctlon and was 
• discharged on the 13th postoperative dav. ;:,he has had no 
respiratory symptoms and her chest roentgenOl.(Tam has been 
normal dunng an 8-month follow-up. 
The resected liver was 484.5 g and 16" h:'" 7 em In size \ Fig. 
2). It was red-brown. rubberY. firm. and shrunken. with mas-
sive areas of necrosIs intermixed with yE~llowlsh nodules of 
intact liver tissue. HistolOgIcally. the liver had extensive ne-
crosIs mixed with areas uf remaining Islands of hepatocytes. 
There was extensive acute and chroniC lnt1ammation. There 
were some regenerating hepatocytes and many proliferating 
cholangIoles. No significant fi.brosls was ~;penK 
isOniaZid hepatotoxlcltv IS conSidered a twpatocellular hy-
persensltlvltv reactIOn that mav cause ddTuse hepatocellu-
lar necrosIs \-/) InitIal elevation of transamll1ases occurs ll1 
10-20'7< of patIents undergOing INH therapy \ /5-17). Typi-
cally. this IS remedied by discontinuation of INH. Although 
the mechanIsm of hepatiC necrosIs IS unknown. once mas-
sive necrosis occurs the damage IS Irreversible and may 
be f:1tal. :'\lortalitv rates from hepatic failure are re-
ported to be 23.21100,000 or 57.91100.000 (9. 18l. In the 
present case. the resected liver showpd massive necrOSIS, 
which was conSidered to be I!TeVerSlble and fatal without 
lIver transplantatIOn. 
ISOnIaZid hepatotoxlcltv resembles \'\ ral hepatitis and IS 
cilagnosed b~D ruling out other pOSSible !·t!ologIes. In the 
present C:lse. hepatitis screens and autoantibodies were 
negative. Alpha-l-antltrvps!l1. Alpha·lt~tEFprotemK copper. and 
ceruloplasmin levels wt're wnhll1 normal ranges. The patient 
developed hepatIc failure;j months alter the ll11t1atlOn of INH 
therapy, 
Liver transplantatIOn has been successful for drug-mduced 
hepatic I'ailure secondarv to kl'toconawle. paracetamol. 
lipexlde. nonsterOIdal ;Intllntlammatorv drugs. sulfasul-
l'alam!l1. halothane, and salazopvnne! 9-11.'. Severe Irrevers-
Ible cases 01 INH-Induced hepatIc latlure reported prevlOuslv 
did not undergo lIver transplantallon. although one patlent 
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r'ICURE '2 The resected liver: weight: 484.5 g, size: 16x lOx7 em. The liver is rubbery. firm. and shrunken. There are r 
necrosIs and small nodular areas of intact ttssue. 
died whIle waiting for transplantation (5l. The present case 
IS the first reported case of INH-induced hepatic failure to 
undergo successful liver transplantation. 
It IS Important to differentiate an Irreversible case from a 
t'('verslble one. Coagulopathy and hyperammonemia, as well 
.IS elevated liver enzymes and bilirubin. which are resistant 
to medical therapy. should reflect Irreversible hepatic necro-
SIS requlnn!! liver transplantatIOn. Additionally, a small cir-
rhotiC ilver seen bv computerized tomography scanning may 
reveal se~ndicant postnecrotic changes. Once these abnor-
malities occur. acute hepatic failure develops. with immedl-
:l te need for transplantation. 
After transplantation. prophylactic antituberculosis medi-
catIOn. exclUSive of INH. was reqUired in our patient who had 
l10t completed her initial course of therapy. Sinnott et al. ( 19) 
have recommended pyrazinamIde for prophylaxis In the 
transplanted patient recelvmg cyclosponne-related immu-
110suppreSSIVCS. We chose to treat our patient with a SIX' 
month course llf the cllmbinatton of pyrazinamide and 
<'lhambutol. The use of two second-line antItuberculoSIS 
medicatIOns was chosen to enhance the mvcobactencidal <le· 
U\'ltV In thiS Immunosuppressed patIent. 
1 n conclUSIOn. II ver transplantatIOn should be conSidered 
fur severe Irreversible INH-induced hepatic failure 
qlpeE~flCel HASAGAWA' 
.'URGE REYES 
B.-\KR :-.; (ll'R 
.\.'WREAS L; T1JWS 
MICHAEL GREENJ 
SATORU 1bDO 
THOMAS E. STARZL' 
The Pittsburf{h TranspiantatLOn Institute 
The Department at" Surgery 
The Department or PedIatriC Inrectious D 
Uniuersltv of Pittsburgh School of MediC! 
Pittsburgh. PcnnsyLuanlO 
: ,\ddress correspondence to Toshimlchl Hasega\ 
plant Surgery. Children's Hospital of Pittsburgh. :3 
DeSoto St .. Pittsburgh. PA 15213-2583. 
I The Department of Pediatnc InfectiOUs Diseast 
, :\ddress requests for reprints to Thomas E. StB 
;-)t ~ Falk Climc. 3601 Fifth Ave .. Pittsburgh. PA 1R~ 
REFERENCES 
Ferebee SH. ~!ount fW. TuberculOSIS morbidl' 
tnal of the prophylactic use of ISOOlaZld amor 
t:lcts. Am Kev Resp Dis 1962: 85 490 
Iseman MD. ~flller B. If a tree tails In the mH 
ISOOlaZld and hepatitis. Am Rev Kesplr DIS . 
I Kumar A. Misra PK. Mehotra RAJ. G"vli ye. 
tlltOXICltv of nfamplO and Isomazld. Am Rev 
1·1:3: 1350. 
I Cold man L. Graman S. !soOlazld: a r('''l{'W " 
.ldverse etlects. Chest 1972: 62. 71. 
:-.iakalo MM. Rao M. Steiner P InCidence "I' 
l'hlldren recelsln~ ISOOlaZld chemoprophvlax 
D,s 1~tl9: H. ti49. 
II Spyndls P. SmamOtl9 C. Papadla 1. Oreopouio 
r-
, 
i 
[April 1994 BrubcCl~CAqflkp 1277 
, S, Papadatos C. Isoniazid liver injury during chemophylaxis in 
• 
children. Arch Dis Child 1979; 54: 65. 
7. Vanderhoof JA, Arment ME. Fatal hepatic necrosis due to iso-
. niazid chemoprophyLaxis in a 15-year-oLd girl. J Pediatr 1976; 
88: 867. 
8. Gal AA, Klatt EC. Fatal isoniazid hepatitis in a child. Pediatr 
Infect Dis 1986; 5: 490. 
I 9. Snider DE, Cras GJ. Isoniazid-associated hepatitis deaths: a 
review of available information. Am Rev Respir Dis 1992; 145: 
494. 
10. O'Grady JG. Wendon J, Tan KC, et al. Liver transpLantation 
after paracetamoL overdose. Br J Med 1991; 303: 221. 
11. Knight TE. Shikuma CY, Knight J. Ketokonazole-induced ful-
minant hepatitis necessitating liver transplantation. J Am 
Acad Dermatol 1991; 25: 398. 
12. Durand F, SamueL D, Bemuau J, et al. Fipexide-induced fulmi-
nant hepatitis: report of three cases with emergency liver 
transplantation. J Hepato11992; 15: 144. 
13. Isai H, Sheil AGR, McCaughan GW, et al. Fulminant hepatic 
failure and liver transplantation. Transplant ?roc 1992; 24: 
1475. 
14. Tzakia A, Todo S, Stanl TE. Orthotopic liver transplantation 
with preservation of the inferior vena cava. Ann Surg 1989; 
210: 649. 
15. Byrd RB, NeLson R, Elliot RC. Isoniazid toxicity: a prospective 
study in secondary chemoprophylaxis. JAmMed A.ssoc 1972; 
220: 1471. 
16. Beaudry PH, Brickman HF, Wise MB, MacDougall D. Liver en-
zyme disturbances during isoniazid chemoprophylaxis in chil-
dren. Am Rev Respir Dis 1974; 110: 581. 
17. Mitchell JR, Zimmerman HJ. Ishak JG. et al. Isoniazid liver 
injury: clinical spectrum, pathology and probable pathogen-
esis. Ann Int Med 1976; 84: 181. 
18. KopanoffDE, Snider DE, Cara GJ. Isoruazid-related hepatitis: a 
US Public Health Service cooperative surveillance study. Am 
Rev Respir Dis 1978; 117: 991. 
19. Sinnott JT. Emmanuel PJ. Mycobacterial infections in the trans-
plant patient. Semin Resp Infect 1990; 5: 65. 
Received 29 September 1993. 
Accepted 21 October 1993. 
TUBERCULOSIS OF TWO CARDIAC ALLOGRAFTS IN ONE PATIENT 
In the developed countries of the Western world, tubercu-
losis in solid organ recipients is an uncommon complication. 
There are some reports by a transplant group in Saudi Arabia 
(1 ~F on tuberculosis in renal allografts; all of their patients 
responded to the classic tuberculostatic therapy. Also tuber-
culosis of the myocardium is a very rare disease (4). In the 
present case report we describe a patient who acquired tu-
berculosis infection in two consecutive heart transplants. 
J.G., 45 years old, was first transplanted on September 26, 
1985, because of terminal cardiomyopathy. The early postop-
erative course was uneventful. For the first ten days after 
transplantation, he receivedATG (3 mglkg/dayl, azathioprine 
(2 mg/kglday), and cyclosporine. The maintenance immuno-
suppressive therapy consisted of cyclosporine and azathio-
prine. There were no signs of viral or bacterial infection. On 
January 14, 1986, a seroconversion occurred from anti-CMV 
IgM/lgG-negative to IgM-positive; as clinical symptoms were 
absent, no antiviral therapy was administered. The 10 en-
do myocardial biopsies (EB)· obtained before March 1986 
showed no rejection or mild rejections. In the EB of March 5. 
1986. granulomas with giant cell formation were observed. 
Clinical examination, NMR imaging, and a tine test were 
negative-furthennore, anamnestic evaluation of the patient 
and the donor as well as the recipients of the other organs 
from the same multiorgan donor brought no additional evi-
dence of tuberculosis, hence tuberculostatic measures did not 
appear to be indicated. 
On December 4. 1986. routine coronary angiography re-
vealed a slight. hemodynamically insignificant, stenosis of 
the nght coronary artery. The same finding was obtained one 
year later. The only complications observed at follow-up were 
repeated renal insufficiency due to cyciosporine nephrotoxic-
ity. By late summer 1989, the patient's general condition had 
deteriorated severely. The coronary angiogram of November 
22, 1989, revealed stenosis of the circumflex artery, typical 
signs of small vessel disease of the left descending artery. and 
• AbbreVlstlon: EB. endomyocardia! biopsy. 
occlusion of the right coronary artery. The function of the left 
ventricle was reduced, with an ejection fraction of 31%. The 
condition of the patient deteriorated accordingly, so he had to 
be retransplanted on July 25, 1990. 
The excised heart. in addition to the angiographically veri-
fied coronary sclerosis and posterior wall infarction, showed 
multiple granulomas with caseous necrosis, interestingly 
only in the left ventricle. Pathohistologically, there were 
granulomas with macrophages, epitheloid, cells and giant 
cells. No acid-resistant rods were identified. The pericardium 
as well as the remaining atria ofthe patient were not affected 
macroscopically. Bacterial smears from the pericardium and 
cultivation for Mycobacterium tuberculosis gave no evidence 
of infection. 
In the postoperative course the patient developed severe 
renal insufficiency necessitating hemofiltration. The ven-
tricular function was nonnal. NMR and CT imaging, per-
fonned to find further manifestations in other organs. yielded 
negative results. As immunosuppressive therapy he received 
methylprednisolone 125 mg every 8 hr on the first postop-
erative day, and thereafter cyclosporine (200 nglml blood, 
measured by HPLC). azathioprine 1 mg/kglday, and low-dose 
steroids (0.2 mglkg/day). Myambutol 3x 400 mg and INH 
2x 300 mg were given as tuberculostatic therapy for only 
four weeks due to poor renal and rapidly deteriorating he-
patic function. At one month after transplantation. EB 
showed moderate rejection. which was resolved by methyl-
prednisolone 1 g for three days. The recovery was pro-
tracted, but nine weeks after the retransplantation the pa-
tient could be discharged. 
From early spring 1991, J.G. complained once more of re-
duced perfonnance. edema, and dyspnea. The coronary an-
giogram showed nonnal morphology, but LVEDP (32 mmHg) 
and pulmonary artery pressure (syst.: 70, diast.: 29, mean: 44 
mmHg) were significantly elevated. The ejection fraction of 
the left ventricle was 32%. Echocardtography revealed that 
the contractility of both ventricles was severely reduced . 
